Wei-Hsin Hsu
Structure-optimized interpolymer polyphosphazene complexes for effective gene delivery against glioblastoma
Hsu, Wei-Hsin; Sánchez-Gómez, Pilar; Gomez-Ibarlucea, Esther; Ivanov, Delyan P.; Rahman, Ruman; Grabowska, Anna M.; Csaba, Noemi; Alexander, Cameron; Garcia-Fuentes, Marcos
Authors
Pilar Sánchez-Gómez
Esther Gomez-Ibarlucea
Delyan P. Ivanov
Professor Ruman Rahman RUMAN.RAHMAN@NOTTINGHAM.AC.UK
PROFESSOR OF MOLECULAR NEURO-ONCOLOGY
Anna M. Grabowska
Noemi Csaba
Professor CAMERON ALEXANDER CAMERON.ALEXANDER@NOTTINGHAM.AC.UK
PROFESSOR OF POLYMER THERAPEUTICS
Marcos Garcia-Fuentes
Abstract
Safe and efficient gene delivery vectors will enhance the prospects for polynucleotide-based therapies. Herein a new approach toward structurally optimized gene vector design based on the preparation of clickable poly(allylamino-phosphazene)s that can be converted to several cationic and anionic derivatives via thiol–ene addition is described. Simultaneous co-incubation of alkylamine- and alkylcarboxylate-poly(phosphazenes) with polynucleotide generates binary polyelectrolyte nanoparticles. Screening of a series of these complexes for transfection in glioblastoma cells shows that the inclusion of 6-mercaptohexanoic acid substituted poly(phosphazene)s in the complexes results in six-fold and 19-fold higher luciferase expression in U87MG cells and GBM1 primary cells, respectively. This effect is attributed to the specific ionization properties of these materials that improved polyplex intracellular trafficking. Transfection in 3D-spheroid models and subcutaneous xenograft U87MG tumors confirms higher transgene expression for the binary cationic/anionic poly(phosphazene) complexes compared to the related polycation-pDNA complexes and to PEI-pDNA complexes. The data also indicate a notable capacity of the mixed complexes to deliver genes to the inner cores of tumor spheroids. Extension of this approach to siRNA delivery shows that the mixed poly(phosphazene) complexes can silence DYRK1A, a gene implicated in glioblastoma initiation and progression, reducing U87MG cell renewal in vitro and delaying tumor growth in vivo.
Citation
Hsu, W.-H., Sánchez-Gómez, P., Gomez-Ibarlucea, E., Ivanov, D. P., Rahman, R., Grabowska, A. M., Csaba, N., Alexander, C., & Garcia-Fuentes, M. (2019). Structure-optimized interpolymer polyphosphazene complexes for effective gene delivery against glioblastoma. Advanced Therapeutics, 2(3), Article 1800126. https://doi.org/10.1002/adtp.201800126
Journal Article Type | Article |
---|---|
Acceptance Date | Nov 16, 2018 |
Online Publication Date | Nov 26, 2018 |
Publication Date | Mar 12, 2019 |
Deposit Date | Dec 5, 2018 |
Publicly Available Date | Dec 5, 2018 |
Journal | Advanced Therapeutics |
Electronic ISSN | 2366-3987 |
Publisher | Wiley-VCH Verlag |
Peer Reviewed | Peer Reviewed |
Volume | 2 |
Issue | 3 |
Article Number | 1800126 |
DOI | https://doi.org/10.1002/adtp.201800126 |
Public URL | https://nottingham-repository.worktribe.com/output/1368015 |
Publisher URL | https://onlinelibrary.wiley.com/doi/full/10.1002/adtp.201800126 |
Files
Structure‐Optimized Interpolymer Polyphosphazene Complexes for Effective Gene Delivery against Glioblastoma
(4.1 Mb)
PDF
You might also like
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search